Post-operative bone growth stimulant introduction method

US10932918B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10932918-B2
Application numberUS-201816163523-A
CountryUS
Kind codeB2
Filing dateOct 17, 2018
Priority dateMar 4, 2014
Publication dateMar 2, 2021
Grant dateMar 2, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of revising a patient having a fusion cage implanted within a spinal column, involving percutaneously delivering a first end of a tube to the spinal column, fluidly connecting the first end of the tube to the fusion cage, and delivering a bone growth agent into the fusion cage through the tube.

First claim

Opening claim text (preview).

We claim: 1. A method of revising a patient having a fusion device having a cavity implanted within a spinal column, comprising the steps of: a) making an incision in the patient having the fusion device having the cavity implanted within the spinal column, b) delivering through the incision a distal end of a tube to the spinal column, c) fluidly connecting the distal end of the tube to the cavity of the fusion device, and d) delivering a bone growth agent into the cavity of the fusion device through the tube, further comprising, between steps c) and d), the step of: e) removing tissue from the cavity of the fusion device. 2. The method of claim 1 wherein tissue removal is accomplished with lavage. 3. The method of claim 1 wherein, in step c), the tube connects to a port on the fusion device. 4. The method of claim 3 wherein the port is associated with a radiographic marker. 5. The method of claim 1 further comprising, before step d), the step of: e) fluidly connecting a bone growth transfer apparatus containing a bone growth agent to a proximal end of the tube. 6. The method of claim 1 further comprising, before step a), the step of: e) radiographically locating the fusion device within the patient. 7. The method of claim 6 wherein step e) includes radiographically aligning a pair of radiopaque rings located in the fusion device. 8. The method of claim 1 further comprising the step of: e) altering a component of the fusion device. 9. The method of claim 8 wherein the alteration is carried out by a step selected from the group consisting of exchanging the component, manipulating the component, adjusting the component, adding a component, and removing a component. 10. The method of claim 1 further comprising the step of: e) delivering additional bone growth agent to a location outside of the fusion device. 11. The method of claim 10 wherein the additional bone growth agent is delivered adjacent a facet joint. 12. The method of claim 1 wherein the bone growth agent travels through the tube by fluid convection. 13. The method of claim 1 wherein the bone growth agent travels through the tube in a solid carrier. 14. The method of claim 13 wherein the solid carrier snaps into the fusion device. 15. The method of claim 13 wherein the solid carrier threads into the fusion device. 16. The method of claim 13 wherein the solid carrier is filled with a collagen sponge during delivery to the fusion device. 17. The method of claim 13 wherein the carrier is filled with a scaffold material during delivery to the fusion device. 18. The method of claim 1 wherein the bone growth agent is flowable.

Assignees

Inventors

Classifications

  • Revision endoprostheses · CPC title

  • Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF] · CPC title

  • Titanium or titanium-based alloys, e.g. Ti-Ni alloys · CPC title

  • Bone or bony tissue · CPC title

  • Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10932918B2 cover?
A method of revising a patient having a fusion cage implanted within a spinal column, involving percutaneously delivering a first end of a tube to the spinal column, fluidly connecting the first end of the tube to the fusion cage, and delivering a bone growth agent into the fusion cage through the tube.
Who is the assignee on this patent?
Depuy Synthes Products Inc
What technology area does this patent fall under?
Primary CPC classification A61F2/30965. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).